Left Menu
Development News Edition

FSII demands govt to restore 200 pc IT deductions for R&D in seed sector

PTI | New Delhi | Updated: 16-01-2020 17:59 IST | Created: 16-01-2020 17:59 IST
FSII demands govt to restore 200 pc IT deductions for R&D in seed sector

Ahead of the Budget, Federation of Seed Industry of India (FSII) on Thursday urged the government to restore 200 per cent income tax deduction for in-house research and development (R&D) expenditure in the seed industry. The income tax deduction for the in-house R&D has been reducing over the last few years. Through an amendment to Finance Act 2016, the weighted deduction was reduced to 150 per cent effective from April 1, 2017 through March 31, 2020 and it indicated a further reduction to 100 per cent from April 1, 2020.

The Act applies to the eligible companies engaged in the business of bio-technology or in any business of manufacturing or production of any article or thing that incurs any expenditure on scientific research (excluding the cost of land) on in-house R&D facility as approved by the Department of Scientific and Industrial Research (DSIR). "As compared to developed economies, R&D investment in India is very low and stands at around 0.7 per cent of GDP. It cannot be ignored that R&D is critical for new technology development, innovations and to achieve the goal of USD 5 trillion economy," FSII Executive Director Shivendra Bajaj said in a statement.

The government will have to encourage higher R&D investment to address emerging challenges of climate change, stagnant yields, increase food production and nutrition needs of the country, he said. Stating that India has potential to become export hub for seeds, the FSII said a "conducive policy support" should be provided by the government.

For instance, varieties such as custom production of both genetically modified (GM) and non-GM seeds and production of export-oriented seeds should be exempted from registration, it said. Registration should be mandatory for seed produced for both domestic and export markets. Export of seed produced in India should be freely allowed without any delays and there should be time bound approvals from National Biodiversity Authority (NBA) for export of these Indian varieties, FSII added.

It also emphasised on the need to have a national policy on seed exports and setting up of a special cell under the Ministry of Agriculture to deal with export promotion and facilitation such as efficient disposal of export and import permits.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

Thailand reports 187 new coronavirus cases, 2 new deaths

Thailand reported 187 new coronavirus cases and two deaths on Monday, bringing the overall number of cases to 13,687 and fatalities to 75 since it detected its first case a year ago.The tally included 10 imported cases, the countrys COVID-1...

No relief to Delhiites from pollution as air quality remains in very poor category

Amid the severe cold conditions in many parts of north-India, the air pollution in the national capital remained in the very poor category with an overall air quality index AQI stood at 339. The System of Air Quality and Weather Forecasting...

FACTBOX-What Australia's first vaccine nod means for national rollout

Australia has taken a cautious approach to approving coronavirus vaccines, a sharp contrast to the rapid, emergency rollouts seen in nations harder hit by the pandemic. On Monday, the countrys Therapeutic Goods Administration TGA gave provi...

Turkey receives 6.5 mln doses of Sinovac vaccine -media

Turkey received 6.5 million further doses of the coronavirus vaccine made by Chinas Sinovac Biotech on Monday, CNN Turk and other media reported, allowing its nationwide rollout to continue.An initial consignment of 3 million doses previous...

Give Feedback